Topcon Medical Systems, Inc. (Oakland, NJ), recently signed an exclusive global licensing agreement for i2k Retina (DualAlign LLC; Clifton Park, NY), a software that enables the registration and high-precision alignment of retinal photographs. The agreement allows Topcon to sell i2K Retina and integrate it with Topcon’s image management system, EyeRoute; and Topcon’s digital imaging system, IMAGEnet.
According to company literature, i2k Retina enables the creation of wide field-of-view mosaics of color fundus images, allowing an optimal view of the retina in a single, seamless display. The software can register and align retinal photographs regardless of which technology was used to capture the photographs or when the photographs were taken. i2k Retina can also align and stabilize fluorescein images of the retina over the stages of circulator filling and can be used to combine color fundus images with fluorescein images, linking the surface appearance to the blood flow images.
Stellaris PC Vision
The Stellaris PC (Procedural Choice) Vision Enhancement System (Bausch + Lomb, Rochester, NY) is a combined vitrectomy and phacoemulsification system. According to company literature, the Stellaris PC, which replaced Bausch + Lomb’s Millennium Microsurgical System, is a versatile system that combines a sleek design, a small footprint, and a wireless footpedal with dual linear control. The device is designed for simplicity and efficiency for easier and faster setup times and less congestion in the OR. The vitreoretinal surgical system comes with xenon and mercury lamp types and surgeon-selected color filters that allow differentiated viewing of ocular tissue under various surgical conditions. Additionally, the Stellaris PC is capable of 1.8-mm microincision cataract surgery phacoemulsification, and it can be used with the company’s transconjunctival sutureless vitrectomy 25-gauge system of instruments for retinal surgery along with 23- and standard 20-gauge instruments. It also comes with Bausch + Lomb’s Stable Chamber tubing system for high vacuum levels without compromising the stability of the chamber and overall safety.
TOP 5 ARTICLES FROM 2010
- A New Treatment for Chronic Central Serous Retinopathy
Micropulse yellow laser resolves leakage and retinal detachment without scarring or retinal damage.
By André Maia, MD, PHD
- Clinical Implications of the BRAVO and CRUISE Trials
How should physicians apply this new information in their treatment of CRVO and BRVO?
By David M. Brown, MD, FACS
- When to Treat and Not to Treat Patients With Central Serous Retinopathy
Reduced-fluence PDT is the current accepted treatment for CSR.
By Francesco Boscia, MD
- Fluidics in Modern Vitrectomy
- Sustained- release Corticosteroid Delivery Systems
Implant technology offers promising solutions to the burden of repeated injections for retinal diseases.
By Szilard Kiss, MD